Therefore, inhibition of ATM proteins is an alternative approach to suppressing tumor growth; in addition, compared to other DDR-targeted agents such as PARP inhibitors, the study of ATM inhibitors is still in the early stages [124]. The gene discussed is ATM; the disease is neoplasm.